tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BioLife Solutions lowers 2025 revenue view to $95M-$96M from $95.5M-$99.0M

2025 revenue consensus $101.3M. 2025 revenue guidance is adjusted for the sale of evo, removing approximately $8M in evo-related revenue. Continues to expect 2025 gross margin in the low-60% range and adjusted gross margin in the mid-60% range, as well as a reduction in net loss and continued expansion of adjusted EBITDA margin, both compared with 2024.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1